Literature DB >> 9672025

Dural arteriovenous fistula in association with heterotopic brain nodule in the transverse sinus.

C Kollar1, I Johnston, G Parker, C Harper.   

Abstract

We describe a 56-year-old woman with a dural arteriovenous fistula involving the transverse sinus in association with a nodule of heterotopic brain tissue in the sinus. This finding is discussed in light of a recent radiologic study of nodules in the transverse sinus.

Entities:  

Mesh：

Year:  1998        PMID： 9672025      PMCID： PMC8338642     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  5 in total

1.  Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.

Authors:  R M Ahmed; M Wilkinson; G D Parker; M J Thurtell; J Macdonald; P J McCluskey; R Allan; V Dunne; M Hanlon; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

Review 2.  Transverse sinus stenting for treatment of papilloedema secondary to a large brain herniation into a dural venous sinus with associated tectal plate lesion: Case report and literature review.

Authors:  Barton Waser; Hannah M Wood; Peter Mews; Shivendra Lalloo
Journal:  Interv Neuroradiol       Date:  2021-03-28       Impact factor: 1.610

3.  Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension.

Authors:  M Bussière; R Falero; D Nicolle; A Proulx; V Patel; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

Review 4.  Brain herniations into arachnoid granulations: about 68 cases in 38 patients and review of the literature.

Authors:  Sonaz Malekzadehlashkariani; Isabel Wanke; Daniel A Rüfenacht; Diego San Millán
Journal:  Neuroradiology       Date:  2016-02-17       Impact factor: 2.804

5.  Temporal Lobe Parenchyma Herniation into the Transverse Sinus: MRI Findings in a Case.

Authors:  Elçin Aydin; Hasan Yerli; Esin Gezmiş
Journal:  J Belg Soc Radiol       Date:  2016-01-29       Impact factor: 1.894
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.